Current Neuropharmacology


F. Nicoletti
University Rome"da Sapienza"

Personal Subscription
Become EABM
Become Reviewer

Meet Our Editorial Board Member free to download

Volume:16   Issue: 6
Pp: 645-646
Maurizio Popoli
DOI: 10.2174/1570159X1606180608103453

Editorial: In Silico Studies in Drug Research Against Neurodegenerative Diseases free to download

Volume:16   Issue: 6
Pp: 647-648
Luciana Scotti* and Marcus T. Scotti*
DOI: 10.2174/1570159X1606180608103840

Current Therapeutic Molecules and Targets in Neurodegenerative Diseases Based on in silico Drug Design

Volume:16   Issue: 6
Pp: 649-663
Sheikh Arslan Sehgal*, Mirza A. Hammad, Rana Adnan Tahir, Hafiza Nisha Akram and Faheem Ahmad
DOI: 10.2174/1570159X16666180315142137

In Silico Studies in Drug Research Against Neurodegenerative Diseases

Volume:16   Issue: 6
Pp: 664-725
Farahnaz Rezaei Makhouri and Jahan B. Ghasemi*
DOI: 10.2174/1570159X15666170823095628

Computer Aided Drug Design and its Application to the Development of Potential Drugs for Neurodegenerative Disorders

Volume:16   Issue: 6
Pp: 740-748
Mohammad Hassan Baig*, Khurshid Ahmad, Gulam Rabbani, Mohd Danishuddin and Inho Choi*
DOI: 10.2174/1570159X15666171016163510

QSAR Modeling of Histamine H3R Antagonists/inverse Agonists as Future Drugs for Neurodegenerative Diseases

Volume:16   Issue: 6
Pp: 749-757
Michelle Fidelis Correa* and Joao Paulo dos Santos Fernandes*
DOI: 10.2174/1570159X15666170818100644

Combining in vitro and in silico Approaches to Find New Candidate Drugs Targeting the Pathological Proteins Related to the Alzheimer's Disease

Volume:16   Issue: 6
Pp: 758-768
Hui Li, Xiaobing Wang, Hongmei Yu, Jing Zhu, Hongtao Jin, Aiping Wang and Zhaogang Yang*
DOI: 10.2174/1570159X15666171030142108

Blood Brain Barrier and Alzheimer’s Disease: Similarity and Dissimilarity of Molecular Alerts

Volume:16   Issue: 6
Pp: 769-785
Alla P. Toropova*, Andrey A. Toropov, Sanija Begum and Patnala G.R. Achary
DOI: 10.2174/1570159X15666171016163951

In Silico Studies Targeting G-protein Coupled Receptors for Drug Research Against Parkinson’s Disease

Volume:16   Issue: 6
Pp: 786-848
Agostinho Lemos, Rita Melo, Antonio Jose Preto, Jose Guilherme Almeida, Irina Sousa Moreira* and Maria Natalia Dias Soeiro Cordeiro*
DOI: 10.2174/1570159X16666180308161642

Alzheimer: A Decade of Drug Design. Why Molecular Topology can be an Extra Edge?

Volume:16   Issue: 6
Pp: 849-864
Riccardo Zanni, Ramon Garcia-Domenech, Maria Galvez-Llompart and Jorge Galvez*
DOI: 10.2174/1570159X15666171129102042

Computer-aided Drug Design Applied to Parkinson Targets

Volume:16   Issue: 6
Pp: 865-880
Hamilton M. Ishiki, Jose Maria Barbosa Filho, Marcelo S. da Silva, Marcus T. Scotti and Luciana Scotti*
DOI: 10.2174/1570159X15666171128145423

3D-QSAR and in-silico Studies of Natural Products and Related Derivatives as Monoamine Oxidase Inhibitors

Volume:16   Issue: 6
Pp: 881-900
Priyanka Dhiman, Neelam Malik and Anurag Khatkar*
DOI: 10.2174/1570159X15666171128143650